期刊文献+

单核细胞宫腔灌注联合冻融胚胎移植治疗反复着床失败:附3例报道 被引量:9

Frozen embryo transfer combined with intrauterine administration of autologous peripheral blood mononuclear cells for repeated implantation failure:report of 3 cases
下载PDF
导出
摘要 目的探讨自体外周血抽提单核细胞宫腔灌注联合冻融胚胎移植治疗反复着床失败的可能性。方法采用单核细胞经HCG培养48 h后与新鲜抽提单核细胞共同宫腔灌注并联合冻融胚胎移植治疗3例反复着床失败患者,并进行文献复习。结果 3例患者进行上述治疗后均获得妊娠并顺利分娩活产儿,母婴追踪至今未见明显异常。结论外周血单核细胞宫腔灌注联合冻融胚胎移植可试用于反复着床失败患者。 Objective To explore the efficacy of frozen-thawed embryo transfer combined with intrauterine administration of autologous peripheral blood mononuclear cells(PBMCs) in the treatment of repeated implantation failure(RIF).Methods PBMCs obtained from 3 patients with RIF on the day of follicle rupture(natural cycle) or when the endometrial thickness reached 8 mm(hormone replacement cycle) were cultured in the presence of HCG for 48 h.The cultured PBMCs,along with freshly isolated PBMCs,were administered into the uterine cavity of the patietns.Vitrified cleavage-stage embryos or blastocysts transfer was performed on day 3 or 5,respectively.Results Vitrified embryo or blastocyst transfer resulted in pregnancy and healthy live births in all the 3 patients.Conclusion Frozen-thawed embryo transfer combined with intrauterine administration of autologous PBMCs may be an effective and safe approach to the treatment of RIF and may improve the outcomes of assisted reproduction.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第4期724-726,共3页 Journal of Southern Medical University
基金 广东省自然科学基金(9151051501000066) 南方医院新技术新项目基金(2006002)
关键词 反复着床失败 单核细胞 外周血 冻融胚胎移植 体外受精-胚胎移植 repeated implantation failure in vitro fertilization and embryo transfer frozen-thawed embryo transfer peripheral blood mononuclear cells
  • 相关文献

参考文献12

  • 1Thornhill AR, deDie-Smulders CE, Geraedts JP, et al. ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)[J]. Hum Reprod, 2005, 20(1): 35-48.
  • 2Margalioth E J, Ben-Chetrit A, Gal M, et al. Investigation and treatment of repeated implantation failure following IVF-ET [J]. Hum Reprod, 2006, 21(12): 3036-43.
  • 3Rijnders PM, Jansen CA. The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in vitro fertilization or intracytoplasmic sperm injection[J]. Hum Reprod, 1998, 13(10): 2869-73.
  • 4Gardner DK, Lane M, Stevens J, et al. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer[J].Fertil Steril, 2000, 73(6): 1155-8.
  • 5孔令红,刘忠,李红,陈思梅,邢福祺.异源淋巴细胞免疫结合IVF-ET治疗伴不孕症的习惯性流产[J].南方医科大学学报,2008,28(7):1300-1301. 被引量:6
  • 6Check JH, Liss J, Check ML, et al. Leukocyte immunotherapy improves live delivery rates following embryo transfer in women with at least two previous failures: a retrospective review[J]. Clin Exp Obstet Gynecol, 2005, 32(2): 85-8.
  • 7Kling C, Steinmann J, Westphal E, et al. Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity[J]. Hum Reprod, 2006, 21(2): 429-35.
  • 8Clark DA. Shall we properly re-examine the status of allogeneic therapy for recurrent early pregnancy failure [J].Am J Reprod Immunol, 2004, 51: 7-15.
  • 9Yoshioka S, Fujiwara H, Nakayama T, et al. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer[J]. Hum Reprod, 2006, 21(12): 3290-4.
  • 10Rubio C, Simon C, Mercader A, et al. Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells[J]. Hum Reprod, 2000, 15 (Suppl)6:31-8.

二级参考文献9

  • 1Coulam CB. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience [ J ]. Am J Reprod Immunol, 1994, 32(4): 286-9.
  • 2Malinowski A, Wilczynski J, Zeman K,et al. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization[J]. Zentralbl Gynakol, 1998, 120(10): 493-502.
  • 3Ng SC, Gilman-Sachs A, Thaker P, et al. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy [J]. Am J Reprod Immunol, 2002, 48(2): 77-86.
  • 4Masuko-Hongo K, Hayashi K, Yonamine K, et al. Disappearance of clonally expanded T cells after allogeneic leukocyte immunotherapy in peripheral blood of patients with habitual abortion [J]. Hum Immunol, 2001, 62(10): 1111-21.
  • 5Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion[J]. 2008,17 [Epub ahead of print].
  • 6Perricone R, De Carolis C, Kroeler B, et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion [J]. Rheumatology (Oxford), 2008, 47(5): 646-5 I.
  • 7Zammiti W, Mtiraoui N, Khairi H. et al. Associations between tumor necrosis factor-alpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage [ J ]. Reprod, 2008, 135(3): 397-403.
  • 8Gharesi-Fatd B, Zolghadri J, Kamali-Sarvestani E. Effect of leukocyte therapy on tumor necrosis factor-alpha and interferon-gamma production in patients with recurrent spontaneous abortion[ J ]. Am J Reprod Immunol, 2008, 59(3): 242-50.
  • 9Matsubayashi H, Sugi T, Arai T, et al. Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients [J]. Am J Reprod Immunol, 2001, 46(5): 323-9.

共引文献5

同被引文献71

  • 1Smitz J. LH and hCG: Their distinct physiological roles and use in ovarian stimulation protocols[M]//Ovarian Stimulation Protocols. Springer India, 2016: 57-69.
  • 2Motta EL, Smith GD, Serafini PC, et al. Human chorionic gonadotropin prior to controlled ovarian stimulation and in vitro fertilization improves implantation, and pregnancy rates [J]. J Assist Reprod Gen,2009, 26(6): 305-311.
  • 3Propst AM, Hill MJ, Bates GW, et al. Low-dose human cho- rionie gonadotropin may improve in vitro fertilization cycle out- comes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration[J]. Fertil Steril,2011,96(4) : 898-904.
  • 4Beretsos P, Partsinevelos GA, Arabatzi E, et al."hCG prim ing" effect in controlled ovarian stimulation through a long protoeol[J].Reprod Biol Endocrinol, 2009,7 (1) : 1-7.
  • 5Serafini P, Yadid I, Motta ELA, et al. Ovarian stimulation with daily late follicular phase administration of low-dose hu- man ehorionic gonadotropin for in vitro fertilization: a pro- spective, randomized trial[J]. Fertil Steril, 2006,86 (4) : 830- 838.
  • 6Koichi K, Yukiko N, Shima K, et al.Efficacy of low-dose hu- man chorionie gonadotropin (hCG) in a GnRH antagonist pro- tocol[J]. J Assist Reprod Gen,2006,23(5) :223-228.
  • 7Filicori M, Fazleabas AT, Huhtaniemi I, et al.Novel concepts of human chorionic gonadotropin: reproductive system interac- tions and potential in the management of infertility[J]. Fertil Steril,2005,84(2) : 275-284.
  • 8Cavagna M, Maldonado LGL, de Souza Bonetti TC, et al.Sup- plementation with a recombinant human chorionic gonadotro- pin mierodose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pitu- itary suppression[J]. Fertil Steril, 2010,94(1):167-172.
  • 9Eiizur SE, Son WY, Clarke H, et al. A unique biological in- vivo model to evaluate follicular development during in-vitro maturation treatment[J]. Reprod Biomed Online, 2011, 22 (3) : 257-262.
  • 10Youssef MA, Van der Veen F, Al-Inany HG, et al. Gonado- tropin-releasing hormone agonist versus hCG for oocyte trig- gering in antagonist-assisted reproductive technology[J]. Co- chrane Database Syst Rev, 2014 Oct, 31 ; 10 : CD008046.

引证文献9

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部